Benefit of 3-D Planning in Total Hip Replacement. A Prospective Randomized Study

NCT ID: NCT05120063

Last Updated: 2023-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

133 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-01

Study Completion Date

2030-01-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective randomized four-armed study the investigators aim to compare wheter 3-D planning, which necessitates preoperative CT acquisition and sophisticated planning together with engineers, results in measurable benefits in terms of objective and subjective outcome values in a collective of patients undergoing primary total hip replacement.

Hypothesis:

1. When compared to 2-D planning, 3-D planning of a THR results in better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.
2. When compared to a non-anatomical stem, an anatomical stem allows better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients sent to our outpatient clinic for eventual primary THR are informed about this study and written patient information given to them. When patients decide to undergo primary total hip replacement, patient's questions with respect to this study are discussed in the outpatient clinic and patients willing to participate included.

Block randomization using closed envelopes for age categories 40-50, 50-60, 60-70 years will be conducted to assign the participant to one of the four study arms.

Patients will be blinded for the type of stem and method of planning. Investigators are blined in terms of methods of planning. In terms of stem design, investigators can not be blinded since their visibility on x-ray does not allow it.

The preoperative investigation includes routine investigation and an additional CT scan plus evaluation of the "University of California at Los Angeles" (UCLA) activity level and "Short Form Health 36" (SF-36) score. The same applies for the postoperative investigation and 3 months. The follow-up visits at 1, 5 and 10 years are routine investigations with additional UCLA and SF-36 Scores.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Injuries Surgery Prosthesis User

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2D anatomical stem

2-D-Planing with anatomical stem (SPS monoblock stem, Symbios)

Group Type EXPERIMENTAL

SPS monoblock stem, Symbios

Intervention Type DEVICE

hip prosthesis

2D planning of THR

Intervention Type PROCEDURE

primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)

2D non anatomical stem

2-D-Planning with non anatomical Stem (Quadra-H, Medacta)

Group Type EXPERIMENTAL

Quadra-H, Medacta

Intervention Type DEVICE

hip prosthesis

2D planning of THR

Intervention Type PROCEDURE

primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)

3D anatomical stem

3-D-Planing with anatomical stem (SPS monoblock stem, Symbios)

Group Type EXPERIMENTAL

SPS monoblock stem, Symbios

Intervention Type DEVICE

hip prosthesis

3D planning of THR

Intervention Type PROCEDURE

primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)

3D non-anatomical stem

3-D-Planing with non anatomical stem (Quadra-H, Medacta)

Group Type EXPERIMENTAL

Quadra-H, Medacta

Intervention Type DEVICE

hip prosthesis

3D planning of THR

Intervention Type PROCEDURE

primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SPS monoblock stem, Symbios

hip prosthesis

Intervention Type DEVICE

Quadra-H, Medacta

hip prosthesis

Intervention Type DEVICE

3D planning of THR

primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)

Intervention Type PROCEDURE

2D planning of THR

primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged 40-70 years scheduled for primary THR
* signed written informed consent.

Exclusion Criteria

* Charnley class B and C
* ASA score \>2
* pregnancy
* gross hip deformity making complex hip reconstruction (greater trochanter advancement, acetabular augmentation, femoral osteotomy, use of cemented or revision stem) necessary
* immature patients and patients incompetent to judge
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Symbios Orthopedie SA

INDUSTRY

Sponsor Role collaborator

Balgrist University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KEK Nr. 2012-0064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lubinus SPII Hip Stem Target Trial Emulation (LARGE)
NCT06367829 ENROLLING_BY_INVITATION
Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING
AMIStem-H Radiographic Analysis
NCT02829866 COMPLETED
ROSA® Hip System THA PMCF
NCT05497206 TERMINATED NA